Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Luszczak S, Kumar C, Sathyadevan VK, Simpson BS, Gately KA, Whitaker HC, Heavey S. Luszczak S, et al. Among authors: simpson bs. Signal Transduct Target Ther. 2020 Jan 31;5(1):7. doi: 10.1038/s41392-020-0109-y. Signal Transduct Target Ther. 2020. PMID: 32296034 Free PMC article. Review.
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Luszczak S, Simpson BS, Stopka-Farooqui U, Sathyadevan VK, Echeverria LMC, Kumar C, Costa H, Haider A, Freeman A, Jameson C, Ratynska M, Ben-Salha I, Sridhar A, Shaw G, Kelly JD, Pye H, Gately KA, Whitaker HC, Heavey S. Luszczak S, et al. Among authors: simpson bs. Sci Rep. 2020 Sep 1;10(1):14380. doi: 10.1038/s41598-020-71263-9. Sci Rep. 2020. PMID: 32873828 Free PMC article.
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Luszczak S, Simpson BS, Stopka-Farooqui U, Sathyadevan VK, Echeverria LMC, Kumar C, Costa H, Haider A, Freeman A, Jameson C, Ratynska M, Ben-Salha I, Sridhar A, Shaw G, Kelly JD, Pye H, Gately KA, Whitaker HC, Heavey S. Luszczak S, et al. Among authors: simpson bs. Sci Rep. 2020 Nov 11;10(1):19870. doi: 10.1038/s41598-020-76679-x. Sci Rep. 2020. PMID: 33177621 Free PMC article.
The oncological relevance of fragile sites in cancer.
Simpson BS, Pye H, Whitaker HC. Simpson BS, et al. Commun Biol. 2021 May 12;4(1):567. doi: 10.1038/s42003-021-02020-5. Commun Biol. 2021. PMID: 33980983 Free PMC article. Review.
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.
Carmona Echeverria LM, Haider A, Freeman A, Stopka-Farooqui U, Rosenfeld A, Simpson BS, Hu Y, Hawkes D, Pye H, Heavey S, Stavrinides V, Norris JM, Bosaily AE, Cardona Barrena C, Bott S, Brown L, Burns-Cox N, Dudderidge T, Henderson A, Hindley R, Kaplan R, Kirkham A, Oldroyd R, Ghei M, Persad R, Punwani S, Rosario D, Shergill I, Winkler M, Ahmed HU, Emberton M, Whitaker HC. Carmona Echeverria LM, et al. Among authors: simpson bs. Sci Rep. 2020 Oct 14;10(1):17177. doi: 10.1038/s41598-020-73524-z. Sci Rep. 2020. PMID: 33057024 Free PMC article.
91 results